More evidence hormone therapy can muddy mammograms
NEW YORK (Reuters Health) - Hormone replacement therapy after menopause may interfere with the accuracy of mammograms used to screen for breast cancer - and the risk may be greater with hormones delivered by patch or injection compared with pills, a new study finds.
Read more...
Reportlinker Adds Men's Health Therapeutics Market to 2016 - Selective Serotonin Reuptake Inhibitors, Hormone ...
Reportlinker.com announces that a new market research report is available in its catalogue:
Read more...
Should 'Male Menopause' Be Treated?
Sweaty, sleepless nights. Inexplicable grouchiness. Weight gain, headaches, and no sex drive. Many women approaching menopause can relate--and so can Mike Coleman.
Read more...
Agile initiates Phase 3 NEW CHOICE Study of AG200-15 contraceptive patch
Agile Therapeutics, Inc., a pharmaceutical development company specializing in women's healthcare products, today announced study initiation and dosing of the first patient in the Company's pivotal, Phase 3 NEW CHOICE Study of AG200-15, Agile's lead contraceptive patch. AG200-15 is designed to effectively deliver a low dose of estrogen in combination with levonorgestrel. The patch is applied ...
Read more...
Research and Markets: This Latest Report on Transdermal Drug Delivery's Technologies, Markets, and Companies is Now ...
DUBLIN----Research and Markets has announced the addition of Jain PharmaBiotech's new report "Transdermal Drug Delivery - Technologies, Markets, and Companies" to their offering.
Read more...
|